|
USP13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.044100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.476600E-03 |
| Normal-vs-Stage2 |
1.546430E-02 |
| Normal-vs-Stage3 |
7.156900E-03 |
| Normal-vs-Stage4 |
7.865700E-02 |
| Stage1-vs-Stage2 |
7.682600E-01 |
| Stage1-vs-Stage3 |
8.023400E-01 |
| Stage1-vs-Stage4 |
7.258000E-01 |
| Stage2-vs-Stage3 |
9.138800E-01 |
| Stage2-vs-Stage4 |
6.082600E-01 |
| Stage3-vs-Stage4 |
6.139800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.812900E-04 |
| Normal-vs-AfricanAmerican |
3.796200E-01 |
| Normal-vs-Asian |
1.064420E-01 |
| Caucasian-vs-AfricanAmerican |
9.554900E-04 |
| Caucasian-vs-Asian |
2.791000E-01 |
| AfricanAmerican-vs-Asian |
5.227900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.397700E-04 |
| Normal-vs-Female |
2.189700E-02 |
| Male-vs-Female |
4.386300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.270500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.584380E-03 |
| Normal-vs-Age(61-80Yrs) |
2.048100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.540030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.693410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.959400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.190400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.501800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.906100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.363700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.424600E-01 |
| Classical-VS-Follicular |
6.317800E-01 |
| Classical-VS-Other |
6.520800E-01 |
| Classical-VS-Normal |
1.356480E-02 |
| Tall-VS-Follicular |
1.454850E-01 |
| Tall-VS-Other |
3.288800E-01 |
| Tall-VS-Normal |
4.712200E-01 |
| Follicular-VS-Other |
7.494200E-01 |
| Follicular-VS-Normal |
6.936700E-03 |
| Other-VS-Normal |
1.288400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.165300E-04 |
| Normal-vs-N1 |
6.395900E-02 |
| N0-vs-N1 |
4.733800E-01 |
|
|
